J3358 Ustekinumab, intravenous inject, 1 milligrams
Also known as: ustekinumab, Stelara, IL-12/23 inhibitor
Ustekinumab intravenous injection 1 milligram is a monoclonal antibody targeting interleukin-12/23 for systemic inflammatory conditions.
In Plain Language
inflammation treatment injection; systemic disease medication
Clinical Context
Indicated for moderate to severe Crohn's disease and ulcerative colitis via intravenous administration. Blocks IL-12 and IL-23 signaling to reduce intestinal inflammation. Administered as induction followed by maintenance infusions.
RVU Information
CPT J3358 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3358?
CPT J3358 (Ustekinumab, intravenous inject, 1 milligrams) is a J Codes (Drugs) code. Ustekinumab intravenous injection 1 milligram is a monoclonal antibody targeting interleukin-12/23 for systemic inflammatory conditions.
How is J3358 administered?
CPT J3358 is administered by a healthcare provider, typically via injection or infusion. Indicated for moderate to severe Crohn's disease and ulcerative colitis via intravenous administration. Blocks IL-12 and IL-23 signaling to reduce intestinal inflammation. Administered as induction followed by maintenance infusions. It is used by Gastroenterology, Infusion Centers, Internal Medicine.
When is CPT J3358 used?
Indicated for moderate to severe Crohn's disease and ulcerative colitis via intravenous administration. Blocks IL-12 and IL-23 signaling to reduce intestinal inflammation. Administered as induction followed by maintenance infusions.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.